Discover Tenders by Computer Terminals Sector

Find the most relevant tenders for Computer Terminals. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Computer Terminals tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Computer Terminals tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Commercial Solutions Opening Cso

Deadline: 31 Dec 2026

United States

Ref. No.: 25320384

EMD:Ref Document

Bid Value: Ref Document

173 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320362

EMD:Ref Document

Bid Value: Ref Document

579 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320331

EMD:Ref Document

Bid Value: Ref Document

579 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Teriparatide

Deadline: 10 Nov 2027

Germany

Ref. No.: 25320290

EMD:Ref Document

Bid Value: Ref Document

487 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Somatropin

Deadline: 10 Aug 2027

Germany

Ref. No.: 25320266

EMD:Ref Document

Bid Value: Ref Document

395 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 Feb 2027

Germany

Ref. No.: 25320246

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Pegfilgrastim

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320219

EMD:Ref Document

Bid Value: Ref Document

579 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 25320192

EMD:Ref Document

Bid Value: Ref Document

30 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Filgrastim

Deadline: 10 Nov 2027

Germany

Ref. No.: 25320105

EMD:Ref Document

Bid Value: Ref Document

487 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Etanercept

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320069

EMD:Ref Document

Bid Value: Ref Document

579 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epoetin Alfa Zeta

Deadline: 10 May 2027

Germany

Ref. No.: 25320041

EMD:Ref Document

Bid Value: Ref Document

303 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Eculizumab

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320009

EMD:Ref Document

Bid Value: Ref Document

579 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Denosumab

Deadline: 10 May 2027

Germany

Ref. No.: 25319971

EMD:Ref Document

Bid Value: Ref Document

303 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Aflibercept Atc S01La05 Excluding Preparations With A Potency Of 114 3 Mg Ml

Deadline: 10 Feb 2027

Germany

Ref. No.: 25319932

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Adalimumab

Deadline: 10 Nov 2026

Germany

Ref. No.: 25319889

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Showing 10366 to 10380 of 11104 results

Discover Tenders by Computer Terminals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Computer Terminals Sector

Filter Your Search

FREE Trial plan for all new users!